A carregar...

Rapamycin increases neuroblastoma xenograft and host stromal derived osteoprotegerin inhibiting osteolytic bone disease in a bone metastasis model

PURPOSE: Osteoprotegerin (OPG) is a decoy receptor for the Receptor of NF-κB (RANK) ligand that can inhibit osteoclastogenesis. Previous studies have suggested that Mammalian Target of Rapamycin (mTOR) inhibition upregulates OPG production. We tested the hypothesis that the mTOR inhibitor rapamycin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hartwich, Joseph E., Orr, W. Shannon, Ng, Catherine Y., Spence, Yunyu, McLaughlin, Jillian M., Furman, Wayne L., McGregor, Lisa M., Davidoff, Andrew M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3584337/
https://ncbi.nlm.nih.gov/pubmed/23331792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpedsurg.2012.10.043
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!